Current advancements and potential strategies in the development of MERS-CoV vaccines

  title={Current advancements and potential strategies in the development of MERS-CoV vaccines},
  author={N. Zhang and S. Jiang and L. Du},
  journal={Expert Review of Vaccines},
  pages={761 - 774}
  • N. Zhang, S. Jiang, L. Du
  • Published 2014
  • Biology, Medicine
  • Expert Review of Vaccines
  • Middle East respiratory syndrome (MERS) is a newly emerging infectious disease caused by a novel coronavirus, MERS-coronavirus (MERS-CoV), a new member in the lineage C of β-coronavirus (β-CoV). The increased human cases and high mortality rate of MERS-CoV infection make it essential to develop safe and effective vaccines. In this review, the current advancements and potential strategies in the development of MERS vaccines, particularly subunit vaccines based on MERS-CoV spike (S) protein and… CONTINUE READING
    Receptor-binding domain-based subunit vaccines against MERS-CoV
    • 47
    • Open Access
    Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
    • 31
    • Open Access
    MERS-CoV spike protein: Targets for vaccines and therapeutics
    • 56
    • Open Access
    Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
    • 49
    • Highly Influenced
    • Open Access
    T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
    • 130
    • Open Access
    Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
    • 46
    • Open Access


    Publications referenced by this paper.
    The spike protein of SARS-CoV — a target for vaccine and therapeutic development
    • 490
    • Highly Influential
    • Open Access
    Effects of a SARS-associated coronavirus vaccine in monkeys
    • 206
    • Open Access
    Rapid generation of a mouse model for Middle East respiratory syndrome
    • 290
    • Open Access